Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 32 | 2024 | 630 | 8.430 |
Why?
|
| Frailty | 4 | 2024 | 98 | 2.800 |
Why?
|
| Kidney Failure, Chronic | 12 | 2024 | 864 | 2.140 |
Why?
|
| Hyperoxaluria, Primary | 6 | 2021 | 12 | 1.770 |
Why?
|
| Living Donors | 6 | 2024 | 112 | 1.700 |
Why?
|
| Pyridoxine | 2 | 2020 | 14 | 1.180 |
Why?
|
| Biomarkers | 3 | 2024 | 2943 | 1.060 |
Why?
|
| Altruism | 2 | 2024 | 25 | 0.970 |
Why?
|
| Cellular Senescence | 1 | 2024 | 162 | 0.860 |
Why?
|
| Nephrectomy | 1 | 2024 | 172 | 0.850 |
Why?
|
| Aftercare | 1 | 2024 | 145 | 0.850 |
Why?
|
| Graft Rejection | 7 | 2024 | 582 | 0.840 |
Why?
|
| Kidney Diseases | 5 | 2021 | 478 | 0.840 |
Why?
|
| Waiting Lists | 2 | 2024 | 225 | 0.760 |
Why?
|
| Self Report | 1 | 2024 | 515 | 0.740 |
Why?
|
| Self-Management | 1 | 2022 | 96 | 0.730 |
Why?
|
| Patient Readmission | 1 | 2024 | 368 | 0.730 |
Why?
|
| Vitamin B Complex | 1 | 2020 | 41 | 0.690 |
Why?
|
| Middle Aged | 27 | 2024 | 25992 | 0.680 |
Why?
|
| Hyperoxaluria | 3 | 2021 | 5 | 0.670 |
Why?
|
| Paraproteinemias | 4 | 2021 | 16 | 0.650 |
Why?
|
| Graft Survival | 7 | 2024 | 525 | 0.610 |
Why?
|
| Adult | 28 | 2024 | 29009 | 0.610 |
Why?
|
| Risk Factors | 13 | 2024 | 10018 | 0.600 |
Why?
|
| Immunoglobulin Light Chains | 4 | 2020 | 26 | 0.590 |
Why?
|
| Hypertension | 2 | 2024 | 1286 | 0.560 |
Why?
|
| Glomerular Filtration Rate | 6 | 2024 | 481 | 0.540 |
Why?
|
| Prognosis | 9 | 2024 | 4512 | 0.520 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 5039 | 0.510 |
Why?
|
| Kidney Function Tests | 4 | 2024 | 126 | 0.510 |
Why?
|
| Kidney | 6 | 2021 | 1335 | 0.510 |
Why?
|
| Amyloidosis | 2 | 2020 | 65 | 0.490 |
Why?
|
| Health Status | 1 | 2017 | 374 | 0.480 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 2 | 2013 | 16 | 0.460 |
Why?
|
| Renal Dialysis | 3 | 2021 | 842 | 0.450 |
Why?
|
| Humans | 46 | 2024 | 123103 | 0.440 |
Why?
|
| Exercise Therapy | 1 | 2015 | 149 | 0.430 |
Why?
|
| Aged | 17 | 2024 | 19093 | 0.430 |
Why?
|
| Female | 30 | 2024 | 65514 | 0.430 |
Why?
|
| Male | 29 | 2024 | 60129 | 0.420 |
Why?
|
| Postoperative Care | 1 | 2015 | 295 | 0.420 |
Why?
|
| Arthritis | 1 | 2013 | 81 | 0.410 |
Why?
|
| Risk Assessment | 4 | 2024 | 3325 | 0.390 |
Why?
|
| Patient Compliance | 1 | 2015 | 464 | 0.390 |
Why?
|
| Prospective Studies | 4 | 2024 | 6028 | 0.370 |
Why?
|
| Potassium Channels | 4 | 1999 | 158 | 0.360 |
Why?
|
| Multiple Myeloma | 2 | 2010 | 169 | 0.360 |
Why?
|
| Oxalates | 3 | 2020 | 32 | 0.360 |
Why?
|
| Kidney Calculi | 1 | 2011 | 42 | 0.360 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 3 | 1999 | 34 | 0.350 |
Why?
|
| Urography | 1 | 2010 | 31 | 0.340 |
Why?
|
| Renal Insufficiency | 2 | 2010 | 234 | 0.340 |
Why?
|
| Hypergammaglobulinemia | 1 | 2010 | 11 | 0.340 |
Why?
|
| Renal Artery | 1 | 2010 | 74 | 0.330 |
Why?
|
| Incidental Findings | 1 | 2010 | 125 | 0.320 |
Why?
|
| Postoperative Complications | 3 | 2024 | 3011 | 0.300 |
Why?
|
| Coronary Angiography | 1 | 2010 | 420 | 0.300 |
Why?
|
| Vascular Diseases | 1 | 2010 | 163 | 0.300 |
Why?
|
| Treatment Outcome | 10 | 2024 | 12115 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2011 | 2055 | 0.280 |
Why?
|
| Quality of Life | 1 | 2017 | 1923 | 0.280 |
Why?
|
| Calcium Oxalate | 3 | 2021 | 24 | 0.270 |
Why?
|
| Urinary Tract Infections | 1 | 2010 | 294 | 0.270 |
Why?
|
| Young Adult | 7 | 2022 | 8855 | 0.260 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 1862 | 0.250 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2016 | 12 | 0.250 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2007 | 274 | 0.250 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2024 | 18 | 0.240 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 248 | 0.220 |
Why?
|
| Transplant Recipients | 2 | 2022 | 209 | 0.220 |
Why?
|
| Survival Analysis | 4 | 2019 | 1473 | 0.210 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 233 | 0.210 |
Why?
|
| Allografts | 3 | 2024 | 190 | 0.210 |
Why?
|
| West Nile Fever | 1 | 2005 | 139 | 0.210 |
Why?
|
| Retrospective Studies | 10 | 2024 | 16044 | 0.200 |
Why?
|
| Minnesota | 2 | 2019 | 132 | 0.190 |
Why?
|
| Myocardium | 3 | 2009 | 986 | 0.190 |
Why?
|
| Cohort Studies | 5 | 2024 | 4699 | 0.190 |
Why?
|
| Opportunistic Infections | 2 | 2013 | 78 | 0.190 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2021 | 7 | 0.190 |
Why?
|
| Adenosine Triphosphate | 2 | 1999 | 287 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 2112 | 0.180 |
Why?
|
| Pancreas Transplantation | 1 | 2020 | 35 | 0.180 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2020 | 10 | 0.180 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2021 | 80 | 0.180 |
Why?
|
| Transaminases | 1 | 2020 | 32 | 0.180 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 115 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 242 | 0.170 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 110 | 0.170 |
Why?
|
| Donor Selection | 1 | 2020 | 52 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 848 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 239 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2008 | 1199 | 0.160 |
Why?
|
| Homozygote | 1 | 2020 | 532 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2020 | 179 | 0.150 |
Why?
|
| Receptors, Drug | 1 | 1998 | 38 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 437 | 0.150 |
Why?
|
| Isoantibodies | 1 | 2018 | 70 | 0.150 |
Why?
|
| Logistic Models | 2 | 2015 | 1797 | 0.150 |
Why?
|
| Inflammation | 1 | 2024 | 1403 | 0.140 |
Why?
|
| Electrocardiography | 1 | 2023 | 957 | 0.140 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 134 | 0.140 |
Why?
|
| Polyomavirus Infections | 1 | 2018 | 90 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2017 | 82 | 0.140 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1998 | 186 | 0.140 |
Why?
|
| Time Factors | 2 | 2024 | 6219 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 6374 | 0.140 |
Why?
|
| Physical Fitness | 1 | 2017 | 91 | 0.140 |
Why?
|
| Tissue Donors | 2 | 2018 | 496 | 0.130 |
Why?
|
| Disease Progression | 2 | 2015 | 2028 | 0.130 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 543 | 0.130 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Polyradiculoneuropathy | 1 | 2015 | 6 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1261 | 0.120 |
Why?
|
| Actigraphy | 1 | 2015 | 44 | 0.120 |
Why?
|
| Sural Nerve | 1 | 2015 | 47 | 0.120 |
Why?
|
| Exercise | 1 | 2020 | 813 | 0.110 |
Why?
|
| Recurrence | 3 | 2016 | 1419 | 0.110 |
Why?
|
| Encephalitozoon cuniculi | 1 | 2013 | 1 | 0.110 |
Why?
|
| Encephalitozoonosis | 1 | 2013 | 1 | 0.110 |
Why?
|
| Complement C3 | 1 | 2013 | 47 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3369 | 0.110 |
Why?
|
| Synovial Fluid | 1 | 2013 | 15 | 0.110 |
Why?
|
| Biopsy | 3 | 2015 | 1236 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 769 | 0.110 |
Why?
|
| Incidence | 3 | 2021 | 3039 | 0.100 |
Why?
|
| Transplantation, Autologous | 2 | 2016 | 297 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3664 | 0.100 |
Why?
|
| Registries | 1 | 2019 | 1394 | 0.100 |
Why?
|
| Survival Rate | 2 | 2014 | 1999 | 0.100 |
Why?
|
| Age Factors | 1 | 2019 | 2799 | 0.100 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 715 | 0.100 |
Why?
|
| Blood Glucose | 2 | 2015 | 1119 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2020 | 1162 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 295 | 0.090 |
Why?
|
| Echocardiography, Stress | 1 | 2010 | 15 | 0.090 |
Why?
|
| Complement C4b | 1 | 2010 | 5 | 0.090 |
Why?
|
| Capillaries | 1 | 2010 | 66 | 0.090 |
Why?
|
| Plasmapheresis | 1 | 2010 | 29 | 0.090 |
Why?
|
| HLA Antigens | 3 | 2020 | 243 | 0.080 |
Why?
|
| COS Cells | 3 | 1999 | 273 | 0.080 |
Why?
|
| Comorbidity | 2 | 2014 | 1497 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2015 | 1325 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2017 | 1015 | 0.080 |
Why?
|
| Pancreas | 2 | 2020 | 211 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2010 | 81 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 586 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2008 | 29 | 0.070 |
Why?
|
| Rabbits | 2 | 1999 | 709 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 329 | 0.070 |
Why?
|
| Urogenital Abnormalities | 1 | 2010 | 169 | 0.070 |
Why?
|
| Troponin T | 1 | 2009 | 245 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2010 | 747 | 0.070 |
Why?
|
| Prevalence | 2 | 2010 | 2395 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2008 | 323 | 0.060 |
Why?
|
| Histocompatibility Testing | 2 | 2020 | 148 | 0.060 |
Why?
|
| Obesity | 2 | 2022 | 2230 | 0.060 |
Why?
|
| Babesiosis | 1 | 2005 | 1 | 0.060 |
Why?
|
| Blood Donors | 1 | 2005 | 62 | 0.060 |
Why?
|
| Lyme Disease | 1 | 2005 | 32 | 0.060 |
Why?
|
| Head | 1 | 2005 | 102 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 2695 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2007 | 622 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 3867 | 0.050 |
Why?
|
| Social Networking | 1 | 2021 | 17 | 0.050 |
Why?
|
| Transplantation, Homologous | 2 | 2016 | 659 | 0.050 |
Why?
|
| Reoperation | 1 | 2024 | 818 | 0.050 |
Why?
|
| Umbilical Cord | 1 | 2021 | 55 | 0.050 |
Why?
|
| Travel | 1 | 2021 | 116 | 0.050 |
Why?
|
| Autoantibodies | 2 | 2016 | 424 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1876 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 65 | 0.040 |
Why?
|
| Social Support | 1 | 2021 | 345 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 157 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2847 | 0.040 |
Why?
|
| Neoplasms | 1 | 2014 | 2755 | 0.040 |
Why?
|
| Fibrosis | 1 | 2021 | 429 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 98 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 1999 | 68 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 186 | 0.040 |
Why?
|
| Sulfonylurea Receptors | 1 | 1998 | 13 | 0.040 |
Why?
|
| Weight Loss | 1 | 2022 | 479 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1998 | 151 | 0.040 |
Why?
|
| Adolescent | 3 | 2013 | 19094 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 1999 | 408 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2020 | 578 | 0.040 |
Why?
|
| Mutagenesis | 1 | 1999 | 347 | 0.040 |
Why?
|
| Hypoglycemia | 1 | 1999 | 191 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2000 | 237 | 0.040 |
Why?
|
| BK Virus | 1 | 2018 | 59 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 274 | 0.030 |
Why?
|
| Child | 2 | 2014 | 24228 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2016 | 60 | 0.030 |
Why?
|
| Antibodies | 1 | 1998 | 371 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 764 | 0.030 |
Why?
|
| Kinetics | 1 | 1998 | 1312 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 527 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2000 | 651 | 0.030 |
Why?
|
| Animals | 4 | 2021 | 33792 | 0.030 |
Why?
|
| Proteinuria | 1 | 2015 | 110 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 1118 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1999 | 816 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2014 | 107 | 0.030 |
Why?
|
| Spores, Fungal | 1 | 2013 | 14 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2000 | 993 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2009 | 859 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 151 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 330 | 0.030 |
Why?
|
| Mortality | 1 | 2014 | 227 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 1999 | 1522 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1306 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 642 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 129 | 0.020 |
Why?
|
| United States | 1 | 2024 | 10651 | 0.020 |
Why?
|
| Survivors | 1 | 2010 | 345 | 0.020 |
Why?
|
| Sinus of Valsalva | 1 | 2007 | 36 | 0.020 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2007 | 42 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 1093 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 439 | 0.010 |
Why?
|
| Calcium | 2 | 1999 | 1096 | 0.010 |
Why?
|
| Glycosyltransferases | 1 | 1999 | 25 | 0.010 |
Why?
|
| Pinacidil | 1 | 1998 | 2 | 0.010 |
Why?
|
| Postprandial Period | 1 | 1999 | 77 | 0.010 |
Why?
|
| C-Peptide | 1 | 1999 | 112 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1998 | 167 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1998 | 95 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 213 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 1999 | 136 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1999 | 173 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 1998 | 86 | 0.010 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1998 | 145 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 1213 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 1068 | 0.010 |
Why?
|
| Syndrome | 1 | 1999 | 1115 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1386 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1999 | 939 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1998 | 795 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 3040 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 5767 | 0.000 |
Why?
|